🎉 M&A multiples are live!
Check it out!

Absci Valuation Multiples

Discover revenue and EBITDA valuation multiples for Absci and other public comps.

See Absci Valuation Multiples

Absci Overview

About Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.


Founded

2011

HQ

United States of America
Employees

156

Website

absci.com

Financials

LTM Revenue $7.3M

LTM EBITDA -$76.8M

EV

$553M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Absci Financials

Absci has a last 12-month revenue of $7.3M and a last 12-month EBITDA of -$76.8M.

In the most recent fiscal year, Absci achieved revenue of $5.7M and an EBITDA of -$95.5M.

Absci expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Absci valuation multiples based on analyst estimates

Absci P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $5.7M $5.7M $6.1M $7.3M XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA -$91.4M -$95.5M -$78.9M -$76.8M XXX
EBITDA Margin -1590% -1669% -1303% -1049% XXX
Net Profit -$101M -$105M -$111M XXX XXX
Net Margin -1757% -1835% -1826% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Absci Stock Performance

As of February 14, 2025, Absci's stock price is $6.

Absci has current market cap of $668M, and EV of $553M.

See Absci trading valuation data

Absci Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$553M $668M XXX XXX XXX XXX $-0.85

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Absci Valuation Multiples

As of February 14, 2025, Absci has market cap of $668M and EV of $553M.

Absci's trades at 75.6x LTM EV/Revenue multiple, and -7.2x LTM EBITDA.

Analysts estimate Absci's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Absci and 10K+ public comps

Absci Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $553M XXX XXX XXX
EV/Revenue 91.4x XXX XXX XXX
EV/EBITDA -7.0x XXX XXX XXX
P/E -6.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Absci Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Absci Valuation Multiples

Absci's NTM/LTM revenue growth is 149%

Absci's revenue per employee for the last fiscal year averaged $37K, while opex per employee averaged $0.6M for the same period.

Over next 12 months, Absci's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Absci's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Absci and other 10K+ public comps

Absci Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 6% XXX XXX XXX XXX
EBITDA Margin -1303% XXX XXX XXX XXX
EBITDA Growth -17% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -1154% XXX XXX XXX XXX
Revenue per Employee $37K XXX XXX XXX XXX
Opex per Employee $0.6M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 841% XXX XXX XXX XXX
Opex to Revenue 1747% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Absci Public Comps

See valuation multiples for Absci public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Benevolent AI XXX XXX XXX XXX XXX XXX
NetraMark XXX XXX XXX XXX XXX XXX
SyntekaBio XXX XXX XXX XXX XXX XXX
Bullfrog AI XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Absci M&A and Investment Activity

Absci acquired  XXX companies to date.

Last acquisition by Absci was  XXXXXXXX, XXXXX XXXXX XXXXXX . Absci acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Absci

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Absci

When was Absci founded? Absci was founded in 2011.
Where is Absci headquartered? Absci is headquartered in United States of America.
How many employees does Absci have? As of today, Absci has 156 employees.
Who is the CEO of Absci? Absci's CEO is Mr. Sean McClain.
Is Absci publicy listed? Yes, Absci is a public company listed on NAS.
What is the stock symbol of Absci? Absci trades under ABSI ticker.
When did Absci go public? Absci went public in 2021.
Who are competitors of Absci? Similar companies to Absci include e.g. Benevolent AI, NetraMark, SyntekaBio, Bullfrog AI.
What is the current market cap of Absci? Absci's current market cap is $668M
What is the current revenue of Absci? Absci's last 12-month revenue is $7.3M.
What is the current EBITDA of Absci? Absci's last 12-month EBITDA is -$76.8M.
What is the current EV/Revenue multiple of Absci? Current revenue multiple of Absci is 75.6x.
What is the current EV/EBITDA multiple of Absci? Current EBITDA multiple of Absci is -7.2x.
What is the current revenue growth of Absci? Absci revenue growth between 2023 and 2024 was 6%.
Is Absci profitable? Yes, Absci is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.